You are here

  • Home
  • Archive
  • Volume 4, Issue 1
  • Fusion of the dendritic cell-targeting chemokine MIP3α to melanoma antigen Gp100 in a therapeutic DNA vaccine significantly enhances immunogenicity and survival in a mouse melanoma model

Citation Tools

Article menu

Download PDFPDF

Research Article
Fusion of the dendritic cell-targeting chemokine MIP3α to melanoma antigen Gp100 in a therapeutic DNA vaccine significantly enhances immunogenicity and survival in a mouse melanoma model

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Gordy JT, Luo K, Zhang H, et al
Fusion of the dendritic cell-targeting chemokine MIP3α to melanoma antigen Gp100 in a therapeutic DNA vaccine significantly enhances immunogenicity and survival in a mouse melanoma model
Journal for ImmunoTherapy of Cancer 2016;4:96. doi: 10.1186/s40425-016-0189-y